These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18695142)

  • 1. Recent clinical trials: the good, the bad, and the misleading.
    Kaplan NM
    Hypertension; 2008 Oct; 52(4):608-9. PubMed ID: 18695142
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent updates for high risk cardiovascular patient and "very" recent updates for the "very" elderly].
    Waeber B; Battegay E
    Praxis (Bern 1994); 2008 May; 97(10):526-7. PubMed ID: 18595367
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulse pressure and dual angiotensin blockade.
    Safar ME
    Am J Hypertens; 2008 Feb; 21(2):133. PubMed ID: 18268484
    [No Abstract]   [Full Text] [Related]  

  • 4. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 6. ARBs vs. ACE inhibitors: which is better for hypertension? ACE inhibitors are generally preferable, but ARBs offer an effective alternative for patients suffering side effects.
    Heart Advis; 2008 Jul; 11(7):4. PubMed ID: 18763362
    [No Abstract]   [Full Text] [Related]  

  • 7. [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].
    Chazova IE
    Ter Arkh; 2003; 75(6):89-91. PubMed ID: 12920969
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood pressure drugs compared. ACE inhibitors beat ARBs hands-down for survival benefit.
    Harv Heart Lett; 2012 Jun; 22(10):5. PubMed ID: 22764400
    [No Abstract]   [Full Text] [Related]  

  • 10. Renin inhibition: what are the clinical perspectives?
    Hollenberg NK
    Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471
    [No Abstract]   [Full Text] [Related]  

  • 12. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
    Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K
    Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
    Tempelhof MW
    South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies].
    Katayama S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740
    [No Abstract]   [Full Text] [Related]  

  • 15. Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.
    Linas SL
    Clin J Am Soc Nephrol; 2008 Jan; 3 Suppl 1(Suppl 1):S17-23. PubMed ID: 18178792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.
    McInnes GT
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S17-20. PubMed ID: 17199214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing complications in diabetic patients: blood pressure control essential.
    Golden W; Kinggard T; Potts SG
    J Ark Med Soc; 2006 Sep; 103(3):58-9. PubMed ID: 16986761
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
    Palmer BF
    Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of combination therapy in hypertension.
    Node K
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.